Literature DB >> 17395544

Comparative plasma pharmacokinetics of meloxicam in sheep and goats following intravenous administration.

Manoj Shukla1, Gurpreet Singh, B G Sindhura, A G Telang, G S Rao, J K Malik.   

Abstract

Meloxicam, a novel cyclooxygenase-2 selective nonsteroidal anti-inflammatory drug (NSAID), has been used extensively in humans and recently in some domestic animal species. Although it is an attractive NSAID for use in small ruminants, meloxicam pharmacokinetics have not been investigated in sheep and goats and this information is essential for rational therapeutic use of the drug in these species. In this investigation, comparative pharmacokinetic properties of meloxicam were studied in sheep and goats after a single intravenous dose of 0.5 mg kg(-1) body mass. Blood samples were collected via jugular venepuncture into heparinised tubes at predetermined times after drug administration. Plasma concentrations of meloxicam were determined by reversed-phase high performance liquid chromatography. The plasma concentrations of meloxicam were detectable in sheep and goats up to 72 and 48 h, respectively. The plasma concentration versus time data of meloxicam in both sheep and goats were adequately described by a two-compartment open model. The values obtained for sheep and goats for distribution half-life, volume of distribution at steady state and volume of the central compartment were almost similar in sheep and goats. The elimination half-life (t(1/2beta)), area under the plasma concentration-time curve (AUC), mean residence time (MRT) and total systemic clearance (Cl(B)) in sheep were significantly different from those of goats. The mean+/-S.E. values of t(1/2beta), MRT, AUC and Cl(B) in sheep were 10.85+/-1.21 h, 15.13+/-1.67 h, 31.88+/-2.97 microg h mL(-1) and 0.016+/-0.002 L h(-1) kg(-1), respectively whereas the respective values in goats were 6.73+/-0.58 h, 9.37+/-0.83 h, 19.23+/-2.23 microg h mL(-1) and 0.03+/-0.01 L h(-1) kg(-1). The results indicate that elimination kinetics of meloxicam differ significantly between sheep and goats and the elimination of the drug tends to be faster in goats compared to sheep.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395544     DOI: 10.1016/j.cbpc.2007.01.020

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  9 in total

1.  Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (Macaca fascicularis).

Authors:  Cassondra Bauer; Patrice Frost; Stephen Kirschner
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

2.  Preliminary Evaluation of Sustained-release Compared with Conventional Formulations of Meloxicam in Sheep (Ovis aries).

Authors:  Misha L Dunbar; Krista J Walkowiak; Jill Schappa Faustich; Aaron K Rendahl; Melanie L Graham
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-03-07       Impact factor: 1.232

Review 3.  Analgesia for Sheep in Commercial Production: Where to Next?

Authors:  Alison Small; Andrew David Fisher; Caroline Lee; Ian Colditz
Journal:  Animals (Basel)       Date:  2021-04-14       Impact factor: 2.752

4.  Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL/6 mice.

Authors:  Joelle C Ingrao; Ron Johnson; Elizabeth Tor; Yu Gu; Marcus Litman; Patricia V Turner
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

5.  In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors.

Authors:  Roula Konsoula; Mira Jung
Journal:  Int J Pharm       Date:  2008-05-13       Impact factor: 5.875

6.  Postpartum meloxicam administration alters plasma haptoglobin, polyunsaturated fatty acid, and oxylipid concentrations in postpartum ewes.

Authors:  Katie E Olagaray; Barry J Bradford; Lorraine M Sordillo; Jeffery C Gandy; Laman K Mamedova; Turner H Swartz; Trey D Jackson; Emma K Persoon; Caitlin S Shugart; Curtis R Youngs
Journal:  J Anim Sci Biotechnol       Date:  2020-07-01

7.  Pharmacokinetics of oral and subcutaneous meloxicam: Effect on indicators of pain and inflammation after knife castration in weaned beef calves.

Authors:  Daniela M Meléndez; Sonia Marti; Edmond A Pajor; Pritam K Sidhu; Désirée Gellatly; Eugene D Janzen; Timothy D Schwinghamer; Johann F Coetzee; Karen S Schwartzkopf-Genswein
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

8.  Plasma pharmacokinetic profile and efficacy of meloxicam administered subcutaneously and intramuscularly to sheep.

Authors:  Alyssa N Woodland; Dominique Van der Saag; Benjamin Kimble; Peter J White; Merran Govendir; Sabrina Lomax
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

9.  Quantitation of meloxicam in the plasma of koalas (Phascolarctos cinereus) by improved high performance liquid chromatography.

Authors:  Benjamin Kimble; Kong Ming Li; Merran Govendir
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.